What's in Guangzhou Yipinhong Pharmaceutical CO.,LTD's pipeline?

Guangzhou Yipinhong Pharmaceutical CO.,LTD has 6 drugs in our index: 4 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Guangzhou Yipinhong Pharmaceutical CO.,LTD's portfolio?

Top competitors by shared drug class: Abeona Therapeutics, Inc, Dipexium Pharmaceuticals, Inc., Hvidovre University Hospital, Maruho Co., Ltd., Tufts Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/guangzhou-yipinhong-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Guangzhou Yipinhong Pharmaceutical CO.,LTD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Guangzhou Yipinhong Pharmaceutical CO.,LTD pipeline: 4 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Fuganlin Oral Liquid	Fuganlin Oral Liquid	marketed
Clindamycin palmitate hydrochloride dispersible tablet	Clindamycin palmitate hydrochloride dispersible tablet	marketed
Xiaoer Jiebiao Oral Liquid	Xiaoer Jiebiao Oral Liquid	marketed			Pediatrics / Infectious Disease
PNA	PNA	marketed	Antimicrobial peptide	Bacterial cell membranes	Infectious diseases

Therapeutic area mix

Cardiovascular · 1
Infectious diseases · 1
Pediatrics / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Abeona Therapeutics, Inc · 1 shared drug class
Dipexium Pharmaceuticals, Inc. · 1 shared drug class
Hvidovre University Hospital · 1 shared drug class
Maruho Co., Ltd. · 1 shared drug class
Tufts Medical Center · 1 shared drug class
United States Naval Medical Center, San Diego · 1 shared drug class
yuanli Zhao · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Guangzhou Yipinhong Pharmaceutical CO.,LTD:

Cite this brief

Drug Landscape (2026). Guangzhou Yipinhong Pharmaceutical CO.,LTD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/guangzhou-yipinhong-pharmaceutical-co-ltd. Accessed 2026-05-17.